DECKERS OUTDOOR CORP
DECKAbout the company
Deckers Outdoor Corporation, together with its subsidiaries, designs, markets, and distributes footwear, apparel, and accessories for casual lifestyle use and high-performance activities in the United States and internationally. The company offers footwear, apparel, and accessories under the UGG brand; footwear, such as running, trail, hiking, fitness, and lifestyle shoes, as well as apparel and accessories under the HOKA brand; and sandals, shoes, and boots under the Teva brand name.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
4 / 6
NEUTRAL / FAIL
Median fair value
$122.82
+58.1% vs price
Models with upside
5 / 16
Positive margin of safety
Strongest signal
8 of 10 pass — Oshaughnessy and Dreman object
Key risk
10 of 11 flag DECK's debt & leverage — Lynch, Buffett, Akre +7 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | O'Shaughnessy Systematic Factor Composite | Lynch GARP | Buffett Quality Compounder | Pabrai Dhandho Framework | Akre Three-Legged Stool | Schloss Asset-Value Discipline | Neff Low-P/E Total Return | Sleep Scale Economies Shared | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Munger Quality Focus | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | NEUTRAL | FAIL | PASS | NEUTRAL | FAIL | FAIL | FAIL | NEUTRAL | PASS | FAIL | PASS | BUY | PASS | NEUTRAL | BUY · Rank #48 (Top 1.5%) | FAIL |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | N/A | N/A | +10.9% | +36.8% | +59.9% | N/A | N/A | N/A | N/A | N/A | +46.0% | +72.6% | N/A | N/A | -21.6% | -45.7% |
| Data As Of | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) |
Where It Passes
- Cash Flow80% pass✓ 10✗ 2▾
8 of 10 pass — Oshaughnessy and Dreman object
(Operating cash flow - capex) / market capitalization+10.17%; #634/4487 (top 14.1%)✗OshaughnessyTop 10% of eligible cross-sectionFCF Positive and Growing$1.1B✓LynchPositive and growingFree Cash Flow Proxy$1.0B✓BuffettPositive and growingP/E or FCF YieldP/E=11.1x, FCF Yield=10.2%✓PabraiP/E < 15 or FCF Yield > 10%Operating Cash Flow - Capital Expenditures$1.1B✓Neff> $0 (app proxy for a strong fundamental case)Positive Operating Cash Flow frequency27/27 years positive✓SleepPositive OCF in >= 70% of available yearsFCF Positive17/18 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap10.2%✓Ackman>= 4%Price / FCF per Share9.8x✓Ackman<= 25Price / (CFO / Shares)9.1x✗Dreman< 8xOperating Cash Flow$1.2B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=32.05%, ROA=27.77%✓PiotroskiCFO/Assets > ROA - Valuation models71% pass✓ 5✗ 2▾
Models split on DECK at $77.68 — fair values range $53.32–$283.06
Buffett fair value$87.14✓Buffett+10.9% margin vs $77.68Pabrai fair value$122.82✓Pabrai+36.8% margin vs $77.68Akre fair value$193.88✓Akre+59.9% margin vs $77.68Munger fair value$143.94✓Munger+46.0% margin vs $77.68Ackman fair value$283.06✓Ackman+72.6% margin vs $77.68Greenblatt fair value$63.89✗Greenblatt-21.6% margin vs $77.68Graham fair value$53.32✗Graham-45.7% margin vs $77.68
Where It Falls Short
- Debt & Leverage9% pass✓ 3✗ 11▾
10 of 11 flag DECK's debt & leverage — Lynch, Buffett, Akre +7 more
Total Debt / Equity✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredDebt/Equity & Interest Coverage✗BuffettD/E < 0.5 AND Interest Coverage > 5xDebt Levels✗AkreDebt/Equity < 0.3✗MungerDebt/Equity < 0.5Total Debt / Shareholders' Equity✗SchlossD/E < 1.00x✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗Dreman< 0.8Current Assets / Current Liabilities3.54x✓SchlossCurrent ratio >= 1.50x (app cutoff)✓Dreman> 1.5Interest Coverage & Debt/EBITDAIC=506.8x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0LT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYLT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current Assets - Growth13% pass✓ 4✗ 9▾
7 of 8 flag DECK's growth — Lynch, Neff, Sleep +4 more
Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -1.7% vs Rev: 9.8%✓LynchInventory growth < Revenue growth3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 55.6% -> 57.7%, operating margin 21.6% -> 23.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR16.5%✓SleepCAGR > 7%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth16.3%✓Ackman>= 5%Positive EPS Growth Frequency✗AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growth - Valuation33% pass✓ 10✗ 16▾
8 of 12 flag DECK's valuation — Oshaughnessy, Lynch, Schloss +5 more
Revenue / market capitalization+0.5072; #2462/5203 (top 47.3%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+9.49%; #637/6251 (top 10.2%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+10.17%; #634/4487 (top 14.1%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-22.39%; #4692/6203 (top 75.6%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)P/E or FCF YieldP/E=11.1x, FCF Yield=10.2%✓PabraiP/E < 15 or FCF Yield > 10%Price / Book Value per Share4.32x✗SchlossP/B <= 0.80x (app cutoff)✗Templeton< 1.5x✗Dreman< 1.2xPrice / Tangible Book Value per Share4.37x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS11.1x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / EPS11.1x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✓Dreman< 12xPrice vs. Trailing Low100% of trailing low ($77.68)✓Templeton<= 120% of trailing low (certified split-adjusted live window)P/B or P/E vs. Historical AverageP/E=11.1x, P/B=4.3x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value✗Marks>= 20% below intrinsic valueValuation ReasonablenessP/E=11.1x, OE Yield=9.4%✓MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share9.8x✓Ackman<= 25Price / (CFO / Shares)9.1x✗Dreman< 8xEBIT / Enterprise Value14.2%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=14.2%, ROC=264.8%✓GreenblattBoth EY > 10% and ROC > 25%Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio4.3x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5 - Profitability40% pass✓ 18✗ 13▾
9 of 15 flag DECK's profitability — Oshaughnessy, Lynch, Buffett +6 more
Net income / market capitalization+9.49%; #637/6251 (top 10.2%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE41.0%✓Lynch> 15%Net Income Positive (10+ years)28/29 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)34.8%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)23.1% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$1.0B✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdMargin of SafetyP/E=11.1x, P/B=4.3x✓PabraiP/B < 1.5 or P/E < 15Return on Equity38.5% (3-yr avg)✓AkreROE > 20% (3-year avg)Positive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 55.6% -> 57.7%, operating margin 21.6% -> 23.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend21.6% (2023) -> 23.1% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value✗Marks>= 20% below intrinsic valuePositive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue23.1%✓Ackman>= 15%Net Income / Shareholders Equity41.0%✓Ackman>= 15%Pre-Tax Income / Revenue19.8%✓Dreman>= 8%Net Income / Shareholders' Equity41.0%✓Dreman> 12%Net Income / Total Assets27.77%✓PiotroskiROA > 0ROA Change YoY27.06% -> 27.77% (delta: +0.71%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=32.05%, ROA=27.77%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY57.9% -> 57.7%✗PiotroskiImproved YoYEBIT / Enterprise Value14.2%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=14.2%, ROC=264.8%✓GreenblattBoth EY > 10% and ROC > 25%Positive EPS (10 years)23/29 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growth - Efficiency50% pass✓ 6✗ 5▾
4 of 8 pass — Akre, Sleep, Munger +1 more object
ROIC (3-5 yr avg)49.8%✓Buffett> 10%ROIC - WACC+39.8%✓BuffettPositive (WACC = 10%)ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of yearsReturn on Invested Capital✗Munger> 15%Current Assets / Current Liabilities3.54✓Dreman> 1.5Current Ratio Change YoY3.72 -> 3.54✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.40x -> 1.48x✓PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)264.8%✓Greenblatt> 25%Current Ratio3.54✓Graham>= 2.0 - Verdicts50% pass✓ 6✗ 6▾
Split decision: 6 FAIL · 4 NEUTRAL · 4 PASS · 1 BUY
Overall verdict•OshaughnessyNEUTRAL (Not ranked)✗LynchFAIL (3/7)✓BuffettPASS (5/9)•PabraiNEUTRAL (2/3)✗AkreFAIL (2/6)✗SchlossFAIL (2/7)✗NeffFAIL (3/6)•SleepNEUTRAL (4/6)✓TempletonPASS (4/8)✗MarksFAIL (3/5)✓MungerPASS (2/4)✓AckmanBUY (7/9)✓DremanPASS (5/11)•PiotroskiNEUTRAL (F-Score 7)✓GreenblattRank #48✗GrahamFAIL (2/9)
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 7.1% of shares last year, 9.6% over two.
- Buybacks
- $1.1B
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $10.8B | $26.5Best. | $3.2Best. | $1.9Best. | $1.4Best. |
| Revenue | $5.5B↑10% | $5.0B↑16% | $4.3B↑18% | $3.6B↑15% | $3.2B |
| Operating Income | $1.3B↑7% | $1.2B↑27% | $927.5M↑42% | $652.8M↑16% | $564.7M |
| Net Income | $1.0B↑6% | $966.1M↑27% | $759.6M↑47% | $516.8M↑14% | $451.9M |
| EPS (Diluted) | $7.02↑11% | $6.33↓78% | $29.16↑51% | $19.37↑19% | $16.26 |
| Gross Margin | 57.7% | 57.9%↑4% | 55.6%↑11% | 50.3%↓1% | 51.0% |
| Operating Margin | 23.1%↓2% | 23.6%↑9% | 21.6%↑20% | 18.0% | 17.9% |
| ROE | 41.0%↑7% | 38.4%↑7% | 36.0%↑23% | 29.3% | 29.4% |
| Total Debt | -- | -- | -- | -- | -- |
| Shareholders' Equity | $2.5B↓1% | $2.5B↑19% | $2.1B↑19% | $1.8B↑15% | $1.5B |
| Current Ratio | 3.54↓5% | 3.72↑9% | 3.39↓12% | 3.84↑19% | 3.23 |
| Debt / Equity | — | — | — | — | — |
| Operating Cash Flow | $1.2B↑13% | $1.0B↑1% | $1.0B↑92% | $537.4M↑212% | $172.4M |
| Free Cash Flow | $1.1B↑15% | $958.4M↑2% | $943.8M↑107% | $456.4M↑276% | $121.3M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
DECK vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.0B | $197.74 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 5/11 |
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| Amer Sports, Inc.AS | $15.2B | $27.24 | $6.6B | $427.4M | 7.4% | 0.14 | 10.7% | 1.50 | 2/9 | 3/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| Gildan Activewear Inc.GIL | $7.9B | $42.62 | $3.6B | $398.9M | 11.2% | 1.21 | 17.1% | 2.11 | 3/9 | 5/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| LEVI STRAUSS & COLEVI | $7.6B | $19.75 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |
| Crocs, Inc.CROX | $6.3B | $126.14 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |